BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2287082)

  • 1. [Proliferative characteristics of the cells].
    Nakamura S
    Rinsho Byori; 1990 Nov; Suppl 87():111-25. PubMed ID: 2287082
    [No Abstract]   [Full Text] [Related]  

  • 2. [General remarks of methods for analyzing proliferative characteristics of the cells].
    Nakamura S
    Rinsho Byori; 1993 Jun; Suppl 94():89-103. PubMed ID: 8361012
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
    Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
    Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
    Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cytometry in the studies of the proliferative activity of neoplastic cells.
    Krygier-Stojalowska A; Kuchnio M; Homenda W; Halajko A
    Acta Histochem Suppl; 1990; 39():67-79. PubMed ID: 2080295
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytometry after bromodeoxyuridine labeling to measure S and G2+M phase durations plus doubling times in vitro and in vivo.
    Terry NH; White RA
    Nat Protoc; 2006; 1(2):859-69. PubMed ID: 17406318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
    Steck K; el-Naggar AK
    Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of cell kinetics for human cancer.
    Bush H
    Eur J Cancer (1965); 1980; Suppl 1():213-8. PubMed ID: 7318862
    [No Abstract]   [Full Text] [Related]  

  • 9. Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependent.
    Powell BL; Gregory BW; Kute TE; Morgan TM; Lyerly ES; Capizzi RL
    Cytometry; 1990; 11(3):438-41. PubMed ID: 2340778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography.
    Costa A; Mazzini G; Del Bino G; Silvestrini R
    Cytometry; 1981 Nov; 2(3):185-8. PubMed ID: 7297353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
    Higashi K; Clavo AC; Wahl RL
    J Nucl Med; 1993 Mar; 34(3):414-9. PubMed ID: 8441032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrochloric acid denaturation of colorectal tumour tissue infiltrated with bromodeoxyuridine.
    Williamson K; Gilliland R; Weir H; Grimes J; Hamilton P; Anderson N; Crockard A; Rowlands B
    Cytometry; 1994 Feb; 15(2):162-8. PubMed ID: 8168403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell kinetics using two labels and flow cytometry.
    Ritter MA; Fowler JF; Kim YJ; Gilchrist KW; Morrissey LW; Kinsella TJ
    Cytometry; 1994 May; 16(1):49-58. PubMed ID: 8033734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of AgNOR analysis in malignant tumors].
    Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):15-22. PubMed ID: 8204559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometric bromodeoxyuridine (BrdU)/DNA analysis--study with urogenital tumors].
    Shimabukuro T; Yoshihiro S; Matsuyama H; Yamamoto N; Sakatoku J
    Hinyokika Kiyo; 1989 Oct; 35(10):1653-7. PubMed ID: 2610171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The application of cytofluorometry to solid tumors for measuring DNA and the S phase].
    Brugarolas A; Pardo-Mindán FJ
    Med Clin (Barc); 1993 Dec; 101(19):750-6. PubMed ID: 8289525
    [No Abstract]   [Full Text] [Related]  

  • 18. Flow cytometry in the diagnosis of brain tumors.
    Rabson AR
    Neurosurg Clin N Am; 1994 Jan; 5(1):135-46. PubMed ID: 8124088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
    Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
    No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation and ploidy of human solid tumours: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry.
    Mazzini G; Danova M; Ferrari C; Giordano M; Dionigi P; Riccardi A
    Anal Cell Pathol; 1996 Mar; 10(2):101-13. PubMed ID: 8721953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.